Review
Jul 2026
MDSCs as the Myeloid Checkpoint: Rethinking Cancer Immunotherapy Through Targeted Modulation
An analysis of current and future therapies targeting MDSCs is presented, focusing on the importance of MDSC heterogeneity in advancing personalized immunotherapies and improving patient outcomes.
S. Mali, Prajakta R. Patil, S. Nangare et al.
· Current Cancer Therapy Revie... · 0 citations